Ticiana Leal, MD
-
RoleMedical Oncology
-
Specialty
-
Research Program
-
Practicing Since2009
Background
Board-certified in medical oncology and palliative care, Ticiana Leal, MD, specializes in treating patients with lung cancer, mesothelioma and thymic malignancies at Winship Cancer Institute.
Dr. Leal is a professor and director of the Thoracic Medical Oncology Program in the Department of Hematology and Medical Oncology at Emory University School of Medicine. She also serves as medical director of the Clinical Trials Office at Winship Cancer Institute.
Before joining Emory, Dr. Leal was on the faculty at UW Carbone Cancer Center in Madison, Wisconsin, where she led the Thoracic Malignancies Disease-Oriented Team.
She earned her medical degree from Federal University of Ceara in Fortaleza, Brazil. She completed her internal medicine residency at Weiss Memorial Hospital in Chicago, followed by a fellowship in geriatric medicine at the University of Illinois at Chicago and a fellowship in medical oncology at University of Wisconsin Hospitals and Clinics in Madison.
Dr. Leal’s clinical research focuses on trials involving chemotherapy and immunotherapy agents for lung cancer.
She has authored or coauthored numerous peer-reviewed research articles, book chapters and posters. She serves as associate editor and executive editorial board member of The Journal of the National Comprehensive Cancer Network. She is also Lung Cancer Section Editor for Current Treatment Options in Oncology and serves on the editorial advisory boards of Cancer and The Brazilian Journal of Oncology.
Titles & Roles
-
Professor, Department of Hematology and Medical OncologyEmory University School of Medicine
-
Medical Director, Clinical Trials OfficeWinship Cancer Institute of Emory University
-
Leader, Lung Cancer Disease TeamWinship Cancer Institute of Emory University
-
Director, Thoracic Medical Oncology Program, Department of Hematology and Medical OncologyEmory University School of Medicine
Education & Training
Education
- Fellowship, Medical Oncology, 2009University of Wisconsin
- Fellowship, Geriatric Medicine, 2007University of Illinois at Chicago
- Residency, Internal Medicine, 2006Weiss Memorial Hospital
- Medical Education, MD, 2001Federal University of Ceara
Professional Memberships
Dr. Leal holds professional memberships with American Society of Clinical Oncology, American Association for Cancer Research, Eastern Cooperative Oncology Group, European Society of Medical Oncology, Society for Immunotherapy of Cancer, and International Association for the Study of Lung Cancer. She is the NCI LUNG-MAP Chair, ECOG-ACRIN representative.
Research
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Grants
| Grant Number | Title |
|---|---|
| 5UG1CA233259-06 | ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center |
Publications
| Title/Journal | Authors | Publication Date |
|---|---|---|
|
Future oncology (London, England) |
S Peters, M Hochmair, KC Arbour, LP Rodriguez, M Reck, T Leal, C R Lindsay, L Shun, WN William, AI Spira, JK Sabari, B Henning Grønberg, M Nishio, TF Burns, N Girard, F Capuzzo, A Merced, N Fasnacht, C Visseren-Grul, MV Negrao | 04/01/2026 |
|
The Journal of clinical investigation |
R Xu, D Wang, G Ma, X Yuan, Q Chu, S Fan, R Zhang, P Du, S Jia, TA Leal, SS Ramalingam, Z Chen, SY Sun | 02/16/2026 |
|
Lung cancer (Amsterdam, Netherlands) |
C Rolfo, DE Gerber, R Kotecha, JP Ward, W Akerley, L Weiss, A Naveh, N Shapira, T Leal, CJ Langer | 12/01/2025 |
|
Oncology and therapy |
B Halmos, N Florez, S Goldberg, W Iams, X Le, T Leal, D Nguyen, LE Raez, JW Riess, J Sabari, D Bjork, N Stigger, Y Xia, P Cifuentes, D D'Andrea, F Shanoon, AL Johnson, ML Johnson | 12/01/2025 |
|
Survival Determinants and Sociodemographic Disparities in Early-Onset Non-Small Cell Lung Cancer. JAMA network open |
I Kar, F Vhora, M Bou Zerdan, K Canaslan, D Balaji, B El Osta, S Balaji, K O'Reilly, T Leal, T Jain, S Ramalingam, CE Steuer, JW Carlisle, S Bozkurt, F Ardeshir-Larijani | 10/01/2025 |
|
Setting Expectations: Using Real-World Data to Guide Patients on Frontline Osimertinib. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer |
JW Carlisle, T Leal | 09/01/2025 |
|
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma. Nature communications |
AH Nassar, C Kim, T Adeyelu, E Bou Farhat, H Abushukair, M Rakaee, K Matteson, SF Lau, Y Takabe, A Ocejo, F Ardeshir-Larijani, T Leal, S Ramalingam, S Alam, JE Gray, J Hicks, D Kaldas, J Baena, MZ Berjaga, FA Nana, C Grohe, H Leuders, F Citarella, A Cortellini, EC Mingo, D Pancirer, M Das, TJ Ellis-Caleo, JM Cheung, JJ Lin, AS Watson, DR Camidge, A Sridhar, K Parikh, F Crowley, TU Marron, V Aggarwal, M Ahmed, K Sankar, H Kawtharany, J Zhang, DH Owen, M Li, M Nagasaka, DJ Pinato, N Awosika, K Alhamad, S Puri, U Zaman, DM Gupta, C Lau, H Khan, J Liauw, AI Velazquez, T Brown, L Moliner, M Mosteiro, P Rocha, M Evans, A Vanderwalde, A Elliott, J Nieva, G Lopes, PC Ma, H Borghaei, M Lee, L Young, R Aljumaily, H Mirza, DJ Kwiatkowski, RS Herbst, RA Flavell, AR Naqash, AC Chiang | 08/19/2025 |
|
Journal for immunotherapy of cancer |
G Durm, H Mamdani, S Althouse, S Perkins, SK Jabbour, AK Ganti, S Jalal, J Chesney, J Naidoo, B Hrinczenko, MJ Fidler, TA Leal, L Feldman, N Fujioka, NH Hanna | 07/15/2025 |
|
Cancer |
TA Leal, Y Wang, A Dowlati, CH Chay, Y Chen, AR Mohindra, M Razaq, HG Ajuja, J Liu, DM King, CJ Sumey, SS Ramalingam | 06/15/2025 |
|
Clinical Outcomes of Perioperative Immunotherapy in Resectable Non-Small Cell Lung Cancer. JAMA network open |
A Desai, K Schwed, L Kalesinskas, Q Yuan, J Bryan, C Keane, E Fidyk, E Castellanos, AB Cohen, K Harrison, G Ho, A Marinescu, TA Leal | 06/02/2025 |
|
Maxing out with chemoimmunotherapy in extensive-stage small cell lung cancer. Chinese clinical oncology |
K Canaslan, L Xiao, T Leal | 04/01/2025 |
|
Sotorasib for the treatment of locally advanced/metastatic non-small cell lung cancer. Future oncology (London, England) |
JP Higgins, JW Carlisle, NH Moniri, S Gupta, EI Oduah, T Leal | 01/01/2025 |
|
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer |
AH Nassar, R Jayakrishnan, J Feng, F Shepherd, E Adib, JM Cheung, JJ Lin, Y Liu, SH Lin, K Parikh, A Sridhar, P Shakya, TJ Dilling, D Kaldas, JE Gray, A Lobachov, J Bar, H Luders, C Grohe, S Gupta, T Leal, B Fitzgerald, F Crowley, Y Fujiwara, TU Marron, M Wilgucki, J Reuss, L Chen, K Sankar, JV Aredo, JW Neal, HA Wakelee, R Thummalapalli, H Yu, R Whitaker, A Velazquez, M Ragavan, A Cortellini, DJ Kwiatkowski, AR Naqash, SB Goldberg, SY Kim | 01/01/2025 |
|
Therapeutic advances in medical oncology |
F Skoulidis, H Borghaei, EB Garon, TA Leal, J Kaufman, SV Liu, E Nadler, SP Patel, S Peters, B Ricciuti, A Gautam, U Emeribe, L Luciani-Silverman, JV Heymach | 01/01/2025 |
|
iScience |
R Sharma, S Sharma, P Shriwas, L Mehta, AH Vu, JK Mouw, J Koo, C Huang, VY Matsuk, C Tucker-Burden, G Joseph, M Behera, SY Sun, MA Roy, M Gilbert-Ross, T Leal, AI Marcus, M Shanmugam | 11/15/2024 |
|
The Journal of experimental medicine |
Z Chen, KA Vallega, D Wang, Z Quan, S Fan, Q Wang, T Leal, SS Ramalingam, SY Sun | 11/04/2024 |
|
JCO global oncology |
SV Liu, A Dasgupta, D Latremouille-Viau, C Rossi, P Rai, F Barlesi, TA Leal | 09/01/2024 |
|
Back to the Drawing Board: Overcoming Resistance to PD-1 Blockade. Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
J Carlisle, Y Liu, T Leal | 07/10/2024 |
|
Cancer |
TA Leal, SS Ramalingam | 06/01/2024 |
|
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer |
AH Nassar, SY Kim, JV Aredo, J Feng, F Shepherd, C Xu, D Kaldas, JE Gray, TJ Dilling, JW Neal, HA Wakelee, Y Liu, SH Lin, T Abuali, A Amini, Y Nie, T Patil, A Lobachov, J Bar, B Fitzgerald, Y Fujiwara, TU Marron, R Thummalapalli, H Yu, DH Owen, J Sharp, S Farid, P Rocha, E Arriola, A D'Aiello, H Cheng, R Whitaker, K Parikh, Y Ashara, L Chen, K Sankar, JP Harris, M Nagasaka, A Ayanambakkam, AI Velazquez, M Ragavan, JJ Lin, Z Piotrowska, M Wilgucki, J Reuss, H Luders, C Grohe, J Baena Espinar, E Feiner, SR Punekar, S Gupta, T Leal, DJ Kwiatkowski, RH Mak, E Adib, AR Naqash, SB Goldberg | 06/01/2024 |
|
International journal of radiation oncology, biology, physics |
MF Bassetti, BA Morris, N Sethakorn, JM Lang, JL Schehr, SG Zhao, ZS Morris, D Buehler, JC Eickhoff, PM Harari, AM Traynor, TC Campbell, AM Baschnagel, TA Leal | 04/01/2024 |
|
The Journal of clinical investigation |
Z Chen, KA Vallega, D Wang, Z Quan, S Fan, Q Wang, T Leal, SS Ramalingam, SY Sun | 03/07/2024 |
|
JCO global oncology |
TA Leal, A Dasgupta, D Latremouille-Viau, C Rossi, P Rai, F Barlesi, SV Liu | 03/01/2024 |
|
Cancer |
NS McCall, JR Janopaul-Naylor, HS McGinnis, AH Kesarwala, S Tian, WA Stokes, JW Shelton, CE Steuer, JW Carlisle, TA Leal, SS Ramalingam, JD Bradley, KA Higgins | 12/01/2023 |
|
Tumor Treating Fields therapy in metastatic non-small-cell lung cancer - Authors' reply. The Lancet. Oncology |
T Leal, C Langer | 12/01/2023 |
|
Advancing immunotherapy in small cell lung cancer. Cancer |
JW Carlisle, T Leal | 11/15/2023 |
|
Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP). JCO precision oncology |
R Vaidya, JM Unger, L Qian, K Minichiello, RS Herbst, DR Gandara, JW Neal, TA Leal, JD Patel, KH Dragnev, SN Waqar, MJ Edelman, EV Sigal, SJ Adam, S Malik, CD Blanke, ML LeBlanc, K Kelly, JE Gray, MW Redman | 09/01/2023 |
|
The Lancet. Oncology |
T Leal, R Kotecha, R Ramlau, L Zhang, J Milanowski, M Cobo, J Roubec, L Petruzelka, L Havel, S Kalmadi, J Ward, Z Andric, T Berghmans, DE Gerber, G Kloecker, R Panikkar, J Aerts, A Delmonte, M Pless, R Greil, C Rolfo, W Akerley, M Eaton, M Iqbal, C Langer | 09/01/2023 |
|
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer |
K He, D Berz, SM Gadgeel, WT Iams, DS Bruno, CM Blakely, AI Spira, MR Patel, DM Waterhouse, DA Richards, A Pham, R Jotte, DS Hong, EB Garon, A Traynor, P Olson, L Latven, X Yan, R Shazer, TA Leal | 07/01/2023 |
|
Spotlight on Small-Cell Lung Cancer and Other Lung Neuroendocrine Neoplasms. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting |
L Fernandez-Cuesta, A Sexton-Oates, L Bayat, M Foll, SCM Lau, T Leal | 05/01/2023 |
|
Cancer |
LC Villaruz, GR Blumenschein, GA Otterson, TA Leal | 05/01/2023 |
|
Clinical lung cancer |
WT Iams, ML Balbach, S Phillips, A Sacher, C Bestvina, V Velcheti, X Wang, ME Marmarelis, N Sethakorn, T Leal, PE Sackstein, C Kim, MA Robinson, K Mehta, R Hsu, J Nieva, T Patil, DR Camidge | 05/01/2023 |
|
Cancer |
T Salous, NA Shukla, SK Althouse, SM Perkins, M Furqan, T Leal, AM Traynor, LE Feldman, NH Hanna, GA Durm | 01/15/2023 |
|
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C. The New England journal of medicine |
R Yaeger, J Weiss, MS Pelster, AI Spira, M Barve, SI Ou, TA Leal, TS Bekaii-Saab, CP Paweletz, GA Heavey, JG Christensen, K Velastegui, T Kheoh, H Der-Torossian, SJ Klempner | 01/05/2023 |
|
Expert review of anticancer therapy |
T Leal, MA Socinski | 01/01/2023 |
|
Cancer medicine |
TA Leal, MN Sharifi, N Chan, R Wesolowski, AA Turk, JY Bruce, RM O'Regan, J Eickhoff, LM Barroilhet, J Malhotra, J Mehnert, E Girda, E Wiley, N Schmitz, S Andrews, G Liu, KB Wisinski | 11/01/2022 |
|
Clinical lung cancer |
BE Osta, J Carlisle, C Steuer, S Pakkala, T Leal, M Dhodapkar, Y Liu, Z Chen, T Owonikoko, S Ramalingam | 11/01/2022 |
|
Clinical lung cancer |
F Ardeshir-Larijani, SK Althouse, T Leal, LE Feldman, TA Hejleh, M Patel, RD Gentzler, AR Miller, NH Hanna | 11/01/2022 |
|
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology |
NS McCall, HS McGinnis, JR Janopaul-Naylor, AH Kesarwala, S Tian, WA Stokes, JW Shelton, CE Steuer, JW Carlisle, T Leal, SS Ramalingam, JD Bradley, KA Higgins | 09/01/2022 |
|
Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
SI Ou, PA Jänne, TA Leal, II Rybkin, JK Sabari, MA Barve, L Bazhenova, ML Johnson, KL Velastegui, C Cilliers, JG Christensen, X Yan, RC Chao, KP Papadopoulos | 08/10/2022 |
|
Lung-MAP: A Collaborative Roadmap to Improve Cancer Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
TA Leal, SE Dahlberg, SS Ramalingam | 07/20/2022 |
|
Neoadjuvant therapy gains FDA approval in non-small cell lung cancer. Cell reports. Medicine |
TA Leal, SS Ramalingam | 07/19/2022 |
|
Nature medicine |
ES Kim, V Velcheti, T Mekhail, C Yun, SM Shagan, S Hu, YK Chae, TA Leal, JE Dowell, ML Tsai, CSR Dakhil, P Stella, Y Jin, DS Shames, E Schleifman, DA Fabrizio, S Phan, MA Socinski | 05/01/2022 |
|
Biomarker research |
JL Schehr, N Sethakorn, ZD Schultz, CI Hernandez, RM Bade, D Eyzaguirre, A Singh, DJ Niles, L Henderson, JW Warrick, SM Berry, KE Sundling, DJ Beebe, TA Leal, JM Lang | 04/25/2022 |
|
Frontiers in rehabilitation sciences |
J Lortie, B Rush, K Osterbauer, TJ Colgan, D Tamada, S Garlapati, TC Campbell, A Traynor, T Leal, V Patel, JJ Helgager, K Lee, SB Reeder, AJ Kuchnia | 01/01/2022 |
|
Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and Ultrasound. Frontiers in rehabilitation sciences |
J Lortie, B Rush, K Osterbauer, TJ Colgan, D Tamada, S Garlapati, TC Campbell, A Traynor, T Leal, V Patel, JJ Helgager, K Lee, SB Reeder, AJ Kuchnia | 01/01/2022 |
|
Molecular cancer therapeutics |
AM Baschnagel, JH Elnaggar, HJ VanBeek, AC Kromke, JH Skiba, S Kaushik, L Abel, PA Clark, CA Longhurst, KP Nickel, TA Leal, SG Zhao, RJ Kimple | 11/01/2021 |
|
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer |
J Malhotra, P Nikolinakos, T Leal, J Lehman, D Morgensztern, JD Patel, JM Wrangle, G Curigliano, L Greillier, ML Johnson, N Ready, G Robinet, S Lally, D Maag, R Valenzuela, V Blot, B Besse | 09/01/2021 |
|
Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
M Reck, D Rodríguez-Abreu, AG Robinson, R Hui, T Csőszi, A Fülöp, M Gottfried, N Peled, A Tafreshi, S Cuffe, M O'Brien, S Rao, K Hotta, TA Leal, JW Riess, E Jensen, B Zhao, MC Pietanza, JR Brahmer | 07/20/2021 |
|
Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
M Boyer, MAN Şendur, D Rodríguez-Abreu, K Park, DH Lee, I Çiçin, PF Yumuk, FJ Orlandi, TA Leal, O Molinier, N Soparattanapaisarn, A Langleben, R Califano, B Medgyasszay, TC Hsia, GA Otterson, L Xu, B Piperdi, A Samkari, M Reck | 07/20/2021 |
|
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021. Journal of the National Comprehensive Cancer Network : JNCCN |
DS Ettinger, DE Wood, DL Aisner, W Akerley, JR Bauman, A Bharat, DS Bruno, JY Chang, LR Chirieac, TA D'Amico, TJ Dilling, J Dowell, S Gettinger, MA Gubens, A Hegde, M Hennon, RP Lackner, M Lanuti, TA Leal, J Lin, BW Loo, CM Lovly, RG Martins, E Massarelli, D Morgensztern, T Ng, GA Otterson, SP Patel, GJ Riely, SE Schild, TA Shapiro, AP Singh, J Stevenson, A Tam, J Yanagawa, SC Yang, KM Gregory, M Hughes | 03/02/2021 |
|
Clinical lung cancer |
TL Enright, JS Witt, AR Burr, P Yadav, T Leal, AM Baschnagel | 03/01/2021 |
|
Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
SV Liu, M Reck, AS Mansfield, T Mok, A Scherpereel, N Reinmuth, MC Garassino, J De Castro Carpeno, R Califano, M Nishio, F Orlandi, J Alatorre-Alexander, T Leal, Y Cheng, JS Lee, S Lam, M McCleland, Y Deng, S Phan, L Horn | 02/20/2021 |
|
Scientific reports |
AM Baschnagel, S Kaushik, A Durmaz, S Goldstein, IM Ong, L Abel, PA Clark, Z Gurel, T Leal, D Buehler, G Iyer, JG Scott, RJ Kimple | 01/28/2021 |
Ratings & Reviews
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.
| 4.8 | Provider showed concern | |
| 4.8 | Provider explained things clearly | |
| 4.8 | Provider discussed treatment options | |
| 4.8 | Provider included you in decisions | |
| 4.9 | Likelihood of recommending this provider |